Mr. drs. Arnold R.J. Croiset van Uchelen – chair
- member of the board since 24 February 2016 – chair since 1 January 2017
Bernard E.M.M. Uyttendaele – treasurer since 24 February 2016
Drs. Jacqueline Detiger – member since 24 February 2016
Glenda I. Nühn-Morris – member since 1 January 2017
Dr. Peter B. Mensing – member since 1 January 2017
PO Box 255, 3300 AG Dordrecht NL
+31 78 635 22 22
Our foundation’s mission is to provide financial support to organisations in the Netherlands and abroad which support good causes, and whose sole or main objective is to organise projects or activities for the benefit of:
- vulnerable groups within society;
- health care;
- creating employment opportunities;
- promoting and carrying out scientific research;
- Dutch cultural heritage; and/or
- Dutch Performing Arts,
and any other project or activity either related or conducive to the interests outlined above, in the broadest sense of the words.
For more information about the policies of various sections of Dioraphte, see:
As of 2015 we publish a 'Year in review' report in Dutch > jaarbericht.
Click here for the 2018 financial overview of the Dioraphte Foundation.
In 2019 the Dioraphte Foundation intends to spend around €14,500,000 on projects, of which around €4.5 million for social initiatives in the four core countries in Africa, €3.5 million for social initiatives in the Netherlands, €3 million on science and research, €2 million on performing arts projects, and €1.5 million on cultural heritage.
The Foundation’s current bylaws describe our policy as follows:
‘The board members do not receive any wages, be it directly or indirectly. The word “wages” does not include reasonable reimbursement of expenses incurred on behalf of the Foundation, nor non-excessive fees. The amount of the fees to be paid to the members is determined by the Board. All reimbursements made to members of the Board will be listed as such in the annual statement of accounts and explained.’
Chamber of Commerce file number 17150595
Legal Person and Joint Venture Reference Number (RSIN) 811835054